课题基金 / 基金详情

xMD-miRNA-Seq estimates cell-specific miRNA expression

xMD-miRNA-Seq estimates cell-specific miRNA expression
xMD-miRNA-Seq 估计细胞特异性 miRNA 表达
批准号:
10240467
负责人:
MARC K HALUSHKA
金额:
$31.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-20 至 2023-08-31

项目摘要

项目成果

MARC K HALUSHKA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract There has been an important realization over the past several years that in order to truly understand human disease we must understand not just the diseased tissues, but rather the cells in those tissues. To that end, we need tools that can capture those cells and explore their expression profiles. We have developed a technology called xMD-miRNA-Seq to do just that. The xMD stands for expression microdissection and it allows us to collect one cell type at a time from any fixed tissue source. We have developed a way to use those cells for small RNA sequencing to capture the expression profile of microRNAs from just these cells. microRNAs (miRNAs) are small, regulatory RNAs involved in disease and development. Although this is an exciting, powerful technique designed to help understand cell expression, it remains relatively inefficient. Therefore, we have proposed a set of optimizations to make the technique widely adaptable. We have proposed to optimize the capture of cells moving from a slide to an affixed membrane by adjusting features including the temperature, the light intensity, the background type and even the membrane itself. We also seek to limit the loss of RNA through the steps of the xMD process by pretreating certain reagents with chemicals designed to remove RNAses. Finally, we will work with both established and new methods to maximize the percent of miRNAs that are read in a small RNA sequencing run. Ultimately, these modifications will greatly enhance the value of the xMD-miRNA-seq method and will allow us to obtain the miRNA profile of almost any human cell type in almost any disease setting. This will be important for cancer biology, immunology, development, cardiovascular disease, neurologic disorders and many other settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
xMD-miRNA-Seq estimates cell-specific miRNA expression
  • 批准号:
    10001551
  • 项目类别:
  • 资助金额:
    $31.11万
  • 财政年份:
    2018
  • 负责人:
    MARC K HALUSHKA
  • 依托单位:
xMD-miRNA-Seq estimates cell-specific miRNA expression
  • 批准号:
    9634161
  • 项目类别:
  • 资助金额:
    $31.11万
  • 财政年份:
    2018
  • 负责人:
    MARC K HALUSHKA
  • 依托单位:
Oncology Tissue
  • 批准号:
    9278342
  • 项目类别:
  • 资助金额:
    $19.62万
  • 财政年份:
    --
  • 负责人:
    MARC K HALUSHKA
  • 依托单位:
Oncology Tissue
  • 批准号:
    9519876
  • 项目类别:
  • 资助金额:
    $19.65万
  • 财政年份:
    --
  • 负责人:
    MARC K HALUSHKA
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究